Loading...
14 Italy Cytology Reports
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Agilent Technologies, Bio-Rad Laboratories, Roche, PerkinElmer, Thermo Fisher Scientific
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Beckton Dickinson, Merck, Roche, Hologic
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Menarini, Miltenyi Biotec, Precision For Medicine (Formerly ApoCell), QIAGEN, Biocept
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Thermo Fisher Scientific, Roche, Agilent Technologies, Bio-Rad Laboratories, Merck
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Roche, Merck, Thermo Fisher Scientific, GE Healthcare, Beckton Dickinson
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: EmCyte, Zimmer Biomet, Johnson & Johnson, Arthrex, Terumo
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: PerkinElmer, Sartorius, Terumo, Danaher, Thermo Fisher Scientific
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Merck, Danaher
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Beckton Dickinson, Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KgaA (Millipore Sigma), Danaher
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Beckton Dickinson, Beckton Dickinson, Bio-Rad Laboratories, Sony Biotechnology, Miltenyi Biotec
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Bio-Rad Laboratories, Cell Signaling Technology, PerkinElmer, Beckton Dickinson, Danaher
Country Covered: Italy
Study Period: 2021 - 2030
Major Players: CORESTEM, Chiesi Farmaceutici, Tego Science, Allogene Therapeutics, Takeda Pharmaceuticals
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Thermo Fisher Scientific, Beckton Dickinson, Terumo, Merck, GE Healthcare
Country Covered: Italy
Study Period: 2019 - 2030
Major Players: Vericel, Pharmicell, Holostem Terapie Avanzate, Opexa Therapeutics, Lineage Cell Therapeutics